01 — Financials
Financial overview
Revenue
USD 9,158,000
Period ending 2024-12-31
Operating profit
USD -45,748,000
Profit before tax
USD -45,201,000
Net profit
USD -38,479,000
Total assets
USD 156,082,000
Equity
USD 140,142,000
Latest reporting period ending 2024-12-31
02 — Signals & news
Recent activity
Data updates
Set up alerts for this company
Get notified about funding, hiring, and leadership changes
03 — Get in touch
Reach NYKODE THERAPEUTICS ASA
Key people
Michael Thyrring Engsig
Daglig leder
Barbara Helene Hannelore Krebs-Pohl
Styre
Christian Åbyholm
Styre
Susanne Stuffers
Styre
Trygve Lauvdal
Styre
Draft an intro emailpro
AI-generated contextual outreach
Prepare a meeting briefpro
One-page summary for your next call
Find decision-makerspro
Search by role and seniority
04 — Similar companies
Companies like NYKODE THERAPEUTICS ASA
Similar company matching coming soon
We're building AI-powered matching based on industry, size, location, and business model
Discover companies in our directory
Search >100,000 Nordic companies by name, industry, or location
Get the full picture on NYKODE THERAPEUTICS ASA
Financial history, alerts, outreach tools, and more. Free to use within limits.
Sign up free